Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- B5257 NTR 368Summary: cytoplasmic peptide of the neurotrophin receptor p75NTR
- B5490 (E)-FeCP-oxindoleSummary: VEGFR-2 inhibitor
- B5491 (Z)-FeCP-oxindoleSummary: VEGFR-2 inhibitor
- B5792 BMS 599626 dihydrochlorideSummary: EGFR and ErbB2 inhibitor,potent and selective
- A8192 Staurosporine6 CitationSummary: serine/threonine protein kinases inhibitor
- N2031 PiceatannolSummary: p56lck/Syk inhibitor
- B6323 AG 99Summary: EGFR inhibitor
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: protein kinase inhibitor
- B6358 Methyl 2,5-dihydroxycinnamateSummary: EGF receptor-associated tyrosine kinases inhibitor
- B6360 Tyrphostin B44, (+) enantiomerSummary: EGFR-kinase inhibitor